Increasing prevalence of dry eye syndrome due to certain diseases, such as rheumatoid arthritis, sjögren’s syndrome, thyroid disease, lupus, blepharitis, entropion, and ectropion is driving growth of the dry eye syndrome market. Increasing consumption of diuretics for high blood pressure, beta-blockers, for heart problems, allergy, sleeping pills, anxiety, antidepressant medicines and heartburn medicines is propelling the growth of the market. Approximately 10 million Americans have had LASIK surgery since it was first approved by the FDA in 1999 and approximately 700,000 LASIK surgeries are done each year. Increasing number of LASIK surgery are driving the growth of the market .
The global market of dry eye syndrome is segmented by type and treatment type.
On the basis of type, the market is segmented into evaporative dry eye syndrome and aqueous dry eye syndrome. Evaporative eye syndrome is leading segment in dry eye syndrome.
Based on the treatment type, the market is segmented into nutritional supplements, serum eye drops, lubricant eye drops, and anti-inflammatory drugs.
Globally, the dry eye syndrome market is divided into four major regions such as North America, Europe, Asia Pacific (APAC), and Latin America and Middle East & Africa (LAMEA).
North America is expected to dominate the global dry eye syndrome increasing computerized work influence eye diseases driving the growth of the dry eye syndrome market. Growing geriatric population is propelling the growth of the market.
Europe is expected to witness strong growth during the forecasted period owing to huge number of eye surgery done in U.K. For instance, approximately 5,000 people in the UK get laser eye surgery each year.
Asia Pacific (APAC) is expected to be the fastest growing region during the forecast period 2019–2026. Rising incidence of dry eye syndrome owing to environmental factors, such as smoke, wind, and dry climates, can increase evaporation of tears. Increasing prevalence of diabetes is another reason for fueling the growth of the market in the coming year.
LAMEA is expecting a steady growth owing to the stringent government policies and per capita income. Additionally, lack of awareness and high price of automated instruments is slowing the market in this region.
Major key players in dry eye syndrome market include Allergan, Alcon, Santen Pharmaceutical Co. Ltd., Shire/SAR code Bioscience, Otsuka Holdings, Can-Fite Biopharma, Novartis, and Eyegate Pharma.
Dry eye syndrome Market Segmentation
By Treatment Type